February 5th, 2024: 7 Ozempic Lawsuits Now Grouped in Federal MDL as Attorneys Accept New Cases As of February 5, 2024, the legal proceedings concerning Ozempic continue, and attorneys are still open to taking on additional cases
Eli Lilly, a US company, manufactures Mounjaro, and Novo Nordisk, a Danish company, produces Ozempic
The Ozempic lawsuit involves allegations that the diabetes medication Ozempic caused severe gastrointestinal issues, pancreatitis, thyroid tumors, or other adverse health effects
It is disclosed here for reader context, not as independent editorial endorsement
But payers shouldn't expect cost relief soon
Our commitment to transparent service means that we always advocate for open communication with your affiliated healthcare provider